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Background: Urinary infections are a common type of pediatric disease, and their treatment and prognosis are
closely correlated with infection location. Common clinical manifestations and laboratory tests are insufficient to
differentiate between acute pyelonephritis and lower urinary tract infection. This study was conducted to explore a
diagnostic method for upper and lower urinary tract infection differentiation.
Methods: The diagnostic values of procalcitonin (PCT) and C-reactive protein (CRP) were analyzed using the
receiver operating characteristic curve method for upper and lower urinary tract infection differentiation. PCT was
determined using chemiluminescent immunoassay.
Results: The PCT and CRP values in children with acute pyelonephritis were significantly higher than those in
children with lower urinary tract infection (3.90 ± 3.51 ng/ml and 68.17 ± 39.42 mg/l vs. 0.48 ± 0.39 ng/ml and 21.39
± 14.92 mg/l). The PCT values were correlated with the degree of renal involvement, whereas the CRP values failed
to show such a significant correlation. PCT had a sensitivity of 90.47% and a specificity of 88% in predicting
nephropathia, whereas CRP had sensitivity of 85.71% and a specificity of 48%.
Conclusions: Both PCT and CRP can be used for upper and lower urinary tract infection differentiation, but PCT has
higher sensitivity and specificity in predicting pyelonephritis than CRP. PCT showed better results than CRP. PCT
values were also correlated with the degree of renal involvement.
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Urinary infections are a common pediatric disease and their
treatment and prognosis are closely correlated with infec-
tion location. Common clinical manifestations and labora-
tory indices are insufficient for acute pyelonephritis and
lower urinary tract infection (UTI) differentiation. Differen-
tiating between these diseases is particularly difficult for in-
fants and children, but is necessary because pyelonephritis
poses a risk of renal parenchyma involvement, which can
lead to renal scar formation, as well as high blood pressure
and end stage renal failure in adults [1-4]. Smellie et al.
conducted a retrospective analysis of 52 patients with neo-
development or progressive renal scars and revealed that
50 of these patients had a medical history of urinary infec-
tion diagnosis or treatment delay [5]. Therefore, finding a* Correspondence: zjqqcn@126.com
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reproduction in any medium, provided the ortechnically easy and practical method for differentiating be-
tween upper and lower UTIs is urgently required.
As of this writing, 99mTc-dimercaptosuccinic acid (DMSA)
scintigraphy is a commonly adopted method for diagnosing
severity degrees of renal involvement and pyelonephritis.
However, this method is costly and is radioactive to sick
children [6,7]. Procalcitonin (PCT) is a type of hormonal
activity-free calcitonin precursor protein that can serve as an
early diagnosis index of serious bacterial infections and septi-
cemia; PCT is also correlated with the severity of bacterial
infections [8-10]. PCT is a satisfactory predictor of renal par-
enchymal involvement in acute and late renal scars [11-13].
We retrospectively analyzed the diagnostic value of PCT
in differentiating upper and lower UTIs, and the serum
PCT level was determined and compared with C-reactive
protein (CRP) and peripheral blood leukocyte count; the
results were subsequently analyzed using the receiver op-
erating characteristic (ROC) method [14,15].This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Table 1 Comparisons of the laboratory outcomes







Lower urine tract infection 0.48 ± 0.39 21.39 ± 14.92 14068 ± 6870
Acute pyelonephritis 3.90 ± 3.51 68.17 ± 39.42 15882 ± 7350
p value < 0.01 < 0.01 > 0.05
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Clinical data
A total of 46 patients with suspected acute pyelonephritis
(APN) were enrolled in the study from December 1999 to
April 2002. Twenty-eight females and 18 males were in-
cluded, and their ages ranged from 2 months old to 14 years
old. Inclusion criteria were as follows: fever (≥38.5°C, axil-
lary), pyuria (≥10 white blood cells per high-power field on
a spun urine), and positive urine culture (≥100,000 col-
onies/ml of a single organism, clean catch). Exclusion cri-
teria included the presence of renal calculi, obstructive
uropathy, and a neurogenic bladder.
We performed a retrospective analysis of 46 admitted
patients, who underwent a DMSA renal scan for sus-
pected APN within 5 d of admission.
APN was confirmed using radioactive nuclide 99mTc-
DMSA scanning. Diagnostic criteria were based on lit-
erature [16]. APN is indicated when radioactive renal
parenchyma distributional sparse or loss areas are present
and accompanied with swelling or a normal kidney profile.
Renal scar formation is diagnosed when the kidney volume
decreases (manifested by cortex attenuation, renal morpho-
logic abnormality, or profile shrinkage) with wedge-shaped
defects. Renal involvement was graded as follows: renal in-
jury <25% was considered mild; renal injury between 25%
and 50% was considered moderate; and renal injury >50%
was considered serious. Lower UTI was diagnosed by nor-
mal DMSA scanning. If the first DMSA findings were ab-
normal, another analysis was performed six months later.
All patients underwent renal ultrasonography within 48 h
of admission, and eight recurrent patients underwent
voiding cystourethrography within 7 d of admission.
Experimental methods
The patients were divided into APN and lower UTI groups
and treated as follows: two weeks of antibiotic treatment for
APN patients, 7 d of antibiotic treatment for Lower UTI.
PCT was determined using chemiluminescent immunoassay,
and CRP was scored using nephrometry scoring. PCT, CRP,
and white blood cell (WBC) count were determined within
24 h of admission and 24 h of therapy.Figure 1 Comparison of the ROC curves of PCT, CRP and WBC.Statistical analysis
All data were normally distributed and were presented as
mean± standard error ( x  s ). T-tests were performed to
compare the means between groups. Cut points were selected
and then graded according to normal, basically normal, sus-
ceptible, basically abnormal, and abnormal classifications. Se
and Sp of each point were calculated. Taking Se as the ordin-
ate, which represented true positive rate, and (1-Sp) as the ab-
scissa, which represented false positive rate. ROC curves were
drawn by the SPSS 10.0 software to calculate the area under
curve and standard errors. The cut-off value was selecteddepending on (Sp + Se)max. Values of different indices were
also compared.
This study was conducted in accordance with the dec-
laration of Helsinki and with approval from the Ethics
Committee of Qilu Hospital of Shan Dong University.
Written informed consent was obtained from all parent
or guardian of participants.
Results
Clinical data
A total of 46 children with urinary infection who received
treatment between December 1999 and April 2002 were en-
rolled. Among the patients, 18 were males and 28 were fe-
males. Their ages ranged from 2 months old to 14 years old:
six males and two females were <1 year old, seven males and
11 females were between 1 year old and 3 years old, and five
males and 15 females were ≥3 years old. A total of 38 pa-
tients had primary urinary infection, and eight had recurrent
infection. Their courses of disease ranged from 3 d to 1 yr.
These patients did not receive antibiotic treatment within
half a month before hospitalization. A total of 40 patients
had body temperatures between 38.5°C and 40.0°C. Twenty-
eight patients presented UTI symptoms, such as frequent
micturition, urgent micturition, odynuria, and crying while
urinating. Twelve patients had lumbago and percussion pain
Table 2 Comparisons of the diagnostic values of PCR, CRP, and WBC for acute pyelonephritis (%)
Index Diagnostic reference value Sensitivity Specificity Accuracy Positive predictive value Negative predictive value
PCT 1 ng/ml 90.47 88 89 87 95
CRP 20 mg/l 85.71 48 86.9 58 80
WBC 15000/mm3 57 44 71 46 55
Table 3 Comparisons between laboratory outcomes and
renal involvement degrees
Index Mild and moderate
degrees (n = 15;
DMSA scanning)
Serious degree
(n = 6; DMSA
scanning)
p values
PCT (ρ/ng · ml-1) 2.02 ± 1.24 8.60 ± 2.80 < 0.01
CRP (ρ/mg · l-1) 62.0 ± 42.83 82.02 ± 28.56 > 0.05
WBC (cells/mm3) 14990 ± 2611 15980 ± 3220 > 0.05
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Eight patients, six of whom were less than 2 years old, pre-
sented non-specific signs and symptoms, such as emesis,
diarrhea, abdominal pain, poor disposition and appetite, ic-
terus, and irritability. All patients had WBC count >10/HP,
12 had red blood cell count of >5/HP, and 11 had urine pro-
tein between + and ++, according to routine urine examin-
ation. Urine culture outcomes of all patients were positive.
Radioactive nuclide scanning
Twenty-one out of the 46 patients were diagnosed with
APN. Among these patients, two had non-obstructive
hydronephrosis, one presented renal scar formation, and
two presented vesico-ureteral reflux.
PCT and CRP
The serum PCT and CRP levels of the APN group were
significantly higher than those of the lower UTI group
(3.90 ± 3.51 ng/ml and 68.17 ± 39.42 mg/l vs. 0.48 ±
0.39 ng/ml and 21.39 ± 14.92 mg/l, P < 0.01, Table 1). Cor-
relation analysis demonstrated that PCT and CRP were in
a significantly positive correlation with a correlation coef-
ficient of 0.729 (P < 0.01).
Curve analysis
As shown in Figure 1, the areas under the PCT, CRP, and
WBC curves were 0.958, 0.858, and 0.588, respectively.
Group comparison analysis showed no significant differ-
ence between the areas under the PCT and CRP curves
(P > 0.05), whereas the areas under these curves were sig-
nificantly larger than that under the WBC curve (P < 0.01).
PCTand CRP are highly accurate in diagnosing APN.
Diagnostic values
The diagnostic values of PCT, CRP, and WBC were
1.0 ng/ml, 20 mg/l, and 15,000/mm3, respectively. The
sensitivity and specificity of PCT in predicting nephro-
pathia were 90.47% and 88%, whereas those of CRP were
85.71% and 48%, respectively. PCT had the highest sen-
sitivity and specificity in diagnosing APN among the
three methods. The results are summarized in Table 2.
Renal involvement degrees
The PCT level in children with serious renal involvement
(8.60 ± 2.80 ng/ml) was noticeably higher than that in chil-
dren with mild and moderate renal involvement (2.02 ±
1.24 ng/ml; P < 0.01), whereas the WBC counts and serumCRP levels among children with different renal involve-
ment degrees did not show significant differences (P >
0.05). High PCT value indicates a serious degree of renal
involvement. The results are summarized in Table 3.PCT and CRP outcome analysis
The pre- and post-treatment PCT levels were 3.90 ± 3.51
and 1.78 ± 2.07 ng/ml, respectively, and the pre- and post-
treatment CRP levels were 68.17 ± 39.42 and 26.13 ±
15.14 mg/l. Great differences in the PCT and CRP were
observed before and after treatment (P < 0.05). Follow-up
DMSA scanning at six months after treatment showed that
15 children completely recovered, three showed great
improvement, two showed little improvement, and one
failed to show noticeable improvement. The child who
failed to show noticeable improvement had renal scars
with vesico-ureteral reflux before the hospitalization,
whereas all other patients had no new scars. The serum
PCT levels (>10 ng/ml) in three patients before treat-
ment were still higher than 5 ng/ml after treatment.Discussion and conclusion
Urinary infections are a common type of pediatric disease,
and their treatment and prognosis are closely associated
with infection position. Differentiating APN from lower
UTI is difficult based on common clinical manifestations
and laboratory indices, and thus, an easier and more prac-
tical method is necessary. 99mTc-DMSA scintigraphy is
currently a commonly adopted method for the diagnosis
of renal involvement degree and pyelonephritis; this
method is costly and radioactive to children [6,7].
PCT is a hormonal activity-free calcitonin precursor
protein [17]. Studies have proven that PCT serves as an
early diagnosis index for bacterial infections and septi-
cemia, and that PCT is also correlated with the severity
of bacterial infections; thus, PCT can predict prognosis
[18-20]. Normally, PCT does not increase when local
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panied by systemic inflammatory reactions [20-22].
Most authors conclude that PCT has satisfactory diag-
nostic accuracy and an interesting clinical value for
APN, with a sensitivity and a specificity ranging from
70% to 100% and 70% to 97%, respectively, across stud-
ies and thresholds [23-28]. However, a Belgium team
found lower sensitivity and specificity (68% and 23%, re-
spectively) with no obvious difference regarding the cut-
off of the characteristics of the population [29]. The
average PCT and CRP levels of children with APN were
greatly higher than those of children with lower UTI
(P < 0.01). In contrast, peripheral blood WBC counts
were not significant in predicting renal involvement.
The areas under the PCT, CRP, and WBC curves were
0.958, 0.858, and 0.588, respectively, and the group ana-
lysis shows that the areas under both PCT and CRP
curves displayed significant differences compared with
those under the WBC curve. Both PCT and CRP can
serve as laboratory indices for APN diagnosis, but PCT
has a higher diagnostic value than CRP. The ROC curves
in this study illustrate the same findings.
This study shows that PCR and CRP have a significant
correlation with a Pearson’s correlation coefficient of 0.729
(P < 0.01). CRP also has a diagnostic value for APN diag-
nosis, but its sensitivity, specificity, and accuracy are low.
The sensitivity and specificity of CRP, PCT, and WBC are
related to a real positive patient’s threshold determination.
Based on the results in this study, 1 ng/ml PCT can be
considered the reference value because PCT has sensitivity
of 90.47%, specificity of 88%, accuracy of 89%, a positive
predictive value of 87%, and a negative predictive value of
95% in predicting APN.
The PCT and CRP levels after treatment significantly
decreased compared with those before treatment (P <
0.05). Both PCT and CRP can be used for observing
pathogenesis and curative effect. The serum PCT value
in children with serious renal involvement was signifi-
cantly higher than in those with mild and moderate
renal involvement. A high PCT value indicates serious
renal involvement. Therefore, PCT can be applied in
predicting renal involvement. The CRP values in chil-
dren with serious renal involvement were higher than
those in children with mild and moderate renal involve-
ment, but no significant difference was observed.
Serum PCT determination is an easy and cheap
method for diagnosing APN, and only a small amount
of blood is required. Furthermore, PCT is highly stable
in serum, and the entire PCT determination process
can be completed in 2 h. PCT determination can also
be used for the observing curative effect and follow-up
pathogenic condition sequelae, prognostic judgment,
and renal involvement degree prediction. Serum PCT
determination can be used in clinical settings.The following are the limitations of this study. First, the
sample size used was small. Second, PCT was initially
measured with a quantitative immunoluminometric assay,
but this assay was progressively replaced by PCT-sensitive
KRYPTOR. Third, validation studies, threshold analyses,
and studies on various effects are required before PCT is
deemed safe for daily use.
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